Efficacy of a preservative-free formulation of fixed-combination bimatoprost and timolol (Ganfort PF) in treatment-naïve patients vs previously treated patients

References

• AdatiaFADamjiKFChronic open-angle glaucoma. Review for primary care physiciansCan Fam Physician2005511229123716190176
   PubMed Web of Science ®Google Scholar
• BagnisAPapadiaMScottoRTraversoCECurrent and emerging medical therapies in the treatment of glaucomaExpert Opin Emerg Drugs201116229330721406029
   PubMed Web of Science ®Google Scholar
• CurranMPOrmanJSBimatoprost/timolol: a review of its use in glaucoma and ocular hypertensionDrugs Aging200926216918419220073
   PubMed Web of Science ®Google Scholar
• GheithMEMayerJRSiamGAMonteiro de BarrosDSThomasTLKatzLJManaging refractory glaucoma with a fixed combination of bimatoprost (0.03%) and timolol (0.5%)Clin Ophthalmol200821152019668385
   PubMedGoogle Scholar
• McKinnonSJGoldbergLDPeeplesPWaltJGBramleyTJCurrent management of glaucoma and the need for complete therapyAm J Manag Care2008141 supplS20S2718284312
   PubMedGoogle Scholar
• KassMAHeuerDKHigginbothamEJThe Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucomaArch Ophthalmol2002120670171312049574
   PubMed Web of Science ®Google Scholar
• Allergan, IncGanfort – Summary of Product CharacteristicsAllergan2006 Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000668/WC500020625.pdfAccessed April 2, 2015
   Google Scholar
• South East Asia Glaucoma Interest GroupAsia Pacific Glaucoma Guidelines2nd ed2008 Available from: http://www.apglaucomasociety.org/toc/APGG2_fullversionNMview.pdfAccessed December 1, 2014
   Google Scholar
• QuarantaLBiagioliERivaIProstaglandin analogs and timolol-fixed versus unfixed combinations or monotherapy for open-angle glaucoma: a systematic review and meta-analysisJ Ocul Pharmacol Ther201329438238923231442
   PubMed Web of Science ®Google Scholar
• HommerARole of fixed combinations in the management of open-angle glaucomaExpert Rev Pharmacoecon Outcomes Res2011111919921351861
   PubMed Web of Science ®Google Scholar
• BrandtJDCantorLBKatzLJBatoosinghALChouCBossowskaIBimatoprost/timolol fixed combination: a 3-month double-masked, randomized parallel comparison to its individual components in patients with glaucoma or ocular hypertensionJ Glaucoma200817321121618414107
   PubMed Web of Science ®Google Scholar
• LewisRAGrossRLSallKNSchiffmanRMLiuCCBatoosinghALThe safety and efficacy of bimatoprost/timolol fixed combination: a 1-year double-masked, randomized parallel comparison to its individual components in patients with glaucoma or ocular hypertensionJ Glaucoma201019642442619855289
   PubMed Web of Science ®Google Scholar
• BaudouinCDetrimental effect of preservatives in eyedrops: implications for the treatment of glaucomaActa Ophthalmol200886771672618537937
   PubMed Web of Science ®Google Scholar
• BaudouinCLabbeALiangHPaulyABrignole-BaudouinFPreservatives in eyedrops: the good, the bad and the uglyProg Retin Eye Res201029431233420302969
   PubMed Web of Science ®Google Scholar
• TrocmeSHwangLJBeanGWSultanMBThe role of benzalkonium chloride in the occurrence of punctate keratitis: a meta-analysis of randomized, controlled clinical trialsAnn Pharmacother201044121914192121119099
   PubMed Web of Science ®Google Scholar
• GoldbergIGil PinaRLanzagorta-ArestiASchiffmanRLiuCBejanianMBimatoprost 0.03%/timolol 0.5% preservative-free ophthalmic solution versus bimatoprost 0.03%/timolol 0.5% ophthalmic solution (Ganfort®) for glaucoma or ocular hypertension: a 12-week randomised controlled trialBr J Ophthalmol201498792693124667994
   PubMed Web of Science ®Google Scholar
• CravenERLiuCCBatoosinghASchiffmanRMWhitcupSMA randomized, controlled comparison of macroscopic conjunctival hyperemia in patients treated with bimatoprost 0.01% or vehicle who were previously controlled on latanoprostClin Ophthalmol201041433144021188155
   PubMedGoogle Scholar
• KatzLJCohenJSBatoosinghALFelixCShuVSchiffmanRMTwelve-month, randomized, controlled trial of bimatoprost 0.01%, 0.0125%, and 0.03% in patients with glaucoma or ocular hypertensionAm J Ophthalmol2010149466167120346780
   PubMed Web of Science ®Google Scholar
• MurphyPJLauJSSimMMWoodsRLHow red is a white eye? Clinical grading of normal conjunctival hyperaemiaEye200721563363816518366
   PubMed Web of Science ®Google Scholar
• HommerAA double-masked, randomized, parallel comparison of a fixed combination of bimatoprost 0.03%/timolol 0.5% with non-fixed combination use in patients with glaucoma or ocular hypertensionEur J Ophthalmol2007171536217294383
   PubMed Web of Science ®Google Scholar
• CordeiroMFGoldbergISchiffmanRBernsteinPLiuCBejanianMEfficacy of a preservative-free fixed combination of bimatoprost and timolol in treatment-naïve versus previously treated patientsActa Ophthalmol201391suppl s252 abstract 4222
   Google Scholar
• ShenJBejanianMSchiffmanRRemoval of preservative from Ganfort improves intraocular pressure (IOP) lowering in patients – a timolol dose-response phenomenonActa Ophthalmol201391suppl s252 abstract 4226
   Google Scholar
• JanulevicieneIKuzmieneLSliesoraityteIComparison of intraocular pressure fluctuations measured by Goldmann applanation tonometer and pulsatile ocular blood flow analyserInt J Biomed Sci20062442843323675012
   PubMedGoogle Scholar
• ZimmermanTJCanalePTimolol – further observationsOphthalmology1979861166169530562
   PubMed Web of Science ®Google Scholar
• RosFEDakeCLTimolol eye drops: bradycardia or tachycardia?Doc Ophthalmol19804822832897398530
   PubMed Web of Science ®Google Scholar
• CherITransfer to timolol: selective use of a new mode of therapyAust J Ophthalmol1980821651727447802
   PubMedGoogle Scholar
• OksalaASalminenLZur tachyphylaxie bei timololbehandlung des chronischen glaukoms. [Tachyphylaxis in timolol therapy for chronic glaucoma]Klin Monbl Augenheilkd19801774451454 German7253493
   PubMed Web of Science ®Google Scholar
• MaclureGMChronic open angle glaucoma treated with timolol. A four year studyTrans Ophthalmol Soc U K1983103pt 178836581640
   PubMedGoogle Scholar
• NeufeldAHInfluences on the density of beta-adrenergic receptors in the cornea and iris-ciliary body of the rabbitInvest Ophthalmol Vis Sci197917110591075
   Google Scholar
• SamamaPBondRARockmanHAMilanoCALefkowitzRJLigand-induced over-expression of a constitutively active β2-adrenergic receptor: pharmacological creation of a phenotype in transgenic miceProc Natl Acad Sci U S A19979411371418990174
   PubMed Web of Science ®Google Scholar
• SchumanJSHorwitzBChoplinNTDavidRAlbrachtDChenKA 1-year study of brimonidine twice daily in glaucoma and ocular hypertension. A controlled, randomized, multicenter clinical trial. Chronic Brimonidine Study GroupArch Ophthalmol199711578478529230823
   PubMed Web of Science ®Google Scholar